Incidence & risk factors of kidney failure in liver transplant patients and need for dialysis
Not Applicable
- Conditions
- Health Condition 1: null- patients with chronic liver disease who underwent Liver transplant
- Registration Number
- CTRI/2017/11/010334
- Lead Sponsor
- Institute of liver and biliary sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age 18-70 years.
2. Liver transplant recipients who received organs from living and cadaver is donors from 1st January 2010 to 31st March 2017
Exclusion Criteria
2. Age <18 years and > 70 years
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to document the serum creatinine values post opertaively and classify these patients into various categories of KDIGO and RIFLE based AKI classification.Timepoint: from post operative day 1 to day 7 of liver transplant surgery
- Secondary Outcome Measures
Name Time Method To evaluate the changes in urine output during various phases of liver transplant surgery and to compare the changes in urine output with AKI and need for CRRT.Timepoint: from post operative day 1 to day 7 of liver transplant surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways contribute to acute kidney injury (AKI) in liver transplant recipients using KDIGO and RIFLE criteria?
How does the incidence of AKI differ between living donor liver transplant (LDLT) and deceased donor liver transplant (DDLT) recipients?
Which biomarkers are associated with acute kidney injury (AKI) in liver transplant patients under KDIGO and RIFLE criteria?
What are the management strategies for acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) in liver transplant recipients?
How do immunosuppressive agents like tacrolimus affect acute kidney injury (AKI) risk and CRRT needs in liver transplant patients?